{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:09:20Z","timestamp":1795133360273,"version":"4.10.3"},"reference-count":62,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Diffuse large B-cell lymphoma (DLBCL), the most common type of lymphoma, arises from various pathogenic mechanisms, including gene translocations and fusions. Detection of gene rearrangements using fluorescence in situ hybridization (FISH) is a standard practice for DLBCL diagnosis and guides treatment decisions. High-throughput chromosome conformation capture (Hi-C) DNA sequencing is a next-generation sequencing\u2013based technology to identify genome-wide rearrangements using a single assay. In this study, Hi-C sequencing was performed using formalin-fixed paraffin-embedded tissues from 159 patients with DLBCL, identifying 746 cancer genes at or proximal to the rearrangement breakpoints, with a total of 1903 occurrences. Focusing on clinically important rearrangements, Hi-C detected 102 rearrangements of MYC, BCL2, and\/or BCL6 in 92 patients and revealed the fusion partners, including 25 rearrangements missed by FISH. Causes of FISH-negative results included FISH-cryptic breakpoints, complex or faint FISH signals, low percentage of FISH positivity, and issues related to tissue fixation. Moreover, in 20 patients (12.6%), Hi-C sequencing detected 22 rearrangements characteristic of other lymphoma types, including CCND1 rearrangements that could lead to reclassification as mantle cell lymphoma. Survival analysis of genome-wide rearrangements using machine learning models identified MYC, PD-L1, CCND1, BCL2, NTRK1\/PRCC, RRAS, and FANCE rearrangements with significant prognostic effects in the DLBCL cohort. In conclusion, Hi-C sequencing detects gene rearrangements crucial for diagnosis in an unbiased and molecular manner and showed high sensitivity and specificity in our study. These advantages of Hi-C sequencing offer help to improve the workflow of clinical pathology laboratories, diagnostic precision, and treatment of large B-cell lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026019675","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:36:18Z","timestamp":1781717778000},"page":"6828-6844","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7615-3949","authenticated-orcid":false,"given":"Zijun Y.","family":"Xu-Monette","sequence":"first","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7999-9627","authenticated-orcid":false,"given":"Chang","family":"Wang","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Wu","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[{"name":"2Department of Histopathology and Autopsy, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-3630","authenticated-orcid":false,"given":"Michael B.","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Odense University Hospital, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-0883","authenticated-orcid":false,"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"4Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-4067","authenticated-orcid":false,"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[{"name":"5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian","family":"Zhao","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1972-7245","authenticated-orcid":false,"given":"Beibei","family":"Lv","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-7858","authenticated-orcid":false,"given":"Bangchen","family":"Wang","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuna","family":"Yao","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-2666","authenticated-orcid":false,"given":"April","family":"Chiu","sequence":"additional","affiliation":[{"name":"5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-435X","authenticated-orcid":false,"given":"Karen","family":"Dybkaer","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Saint Louis University School of Medicine, SSM Health, Saint Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youli","family":"Zu","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Houston Methodist Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-8262","authenticated-orcid":false,"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[{"name":"10Translational Hematopathology Laboratory and Anatomic Pathology Department, Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-3356","authenticated-orcid":false,"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[{"name":"11Department of Pathology, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Bernal-Mizrachi","sequence":"additional","affiliation":[{"name":"12Department of Cancer Medicine, Wake Forest University School of Medicine, Winston-Salem, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Han van Krieken","sequence":"additional","affiliation":[{"name":"13Radboud University Nijmegen Medical Center, Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Choi","sequence":"additional","affiliation":[{"name":"14Department of Pathology, Hong Kong Sanatorium & Hospital, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tam","sequence":"additional","affiliation":[{"name":"15Department of Pathology, Northwell Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-4371","authenticated-orcid":false,"given":"Weina","family":"Chen","sequence":"additional","affiliation":[{"name":"16Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-325X","authenticated-orcid":false,"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"17Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-6124","authenticated-orcid":false,"given":"Andr\u00e9s J. M.","family":"Ferreri","sequence":"additional","affiliation":[{"name":"18Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-2937","authenticated-orcid":false,"given":"Benjamin M.","family":"Parsons","sequence":"additional","affiliation":[{"name":"19Department of Medical Oncology, Gundersen Health System, La Crosse, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0148-9122","authenticated-orcid":false,"given":"Farzaneh","family":"Khajouei","sequence":"additional","affiliation":[{"name":"20Arima Genomics, Carlsbad, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-0622","authenticated-orcid":false,"given":"Kristin","family":"Sikkink","sequence":"additional","affiliation":[{"name":"20Arima Genomics, Carlsbad, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-1714","authenticated-orcid":false,"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"21Center for Molecular Oncology and Cellular Therapeutics, Children\u2019s Mercy Hospital, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5829-2649","authenticated-orcid":false,"given":"Alex R.","family":"Hastie","sequence":"additional","affiliation":[{"name":"20Arima Genomics, Carlsbad, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"20Arima Genomics, Carlsbad, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-8932","authenticated-orcid":false,"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[{"name":"1Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC"},{"name":"22Duke Cancer Institute, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"9","key":"2026101310430996600_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra2027612","article-title":"Diffuse large B-cell lymphoma","volume":"384","author":"Sehn","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"2026101310430996600_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"2026101310430996600_bib3","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers15082285","article-title":"Large B-cell lymphomas in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new concepts","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"18","key":"2026101310430996600_bib4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"issue":"15","key":"2026101310430996600_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood.2024025603","article-title":"Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2","volume":"144","author":"Collinge","year":"2024","journal-title":"Blood"},{"key":"2026101310430996600_bib6","doi-asserted-by":"crossref","first-page":"2632010X241230262","DOI":"10.1177\/2632010X241230262","article-title":"RNAseq analysis for accurate identification of fusion partners in tumor specific translocations detected by standard FISH probes in hematologic malignancies","volume":"17","author":"Koduru","year":"2024","journal-title":"Clin Pathol"},{"issue":"3","key":"2026101310430996600_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41375-023-02134-1","article-title":"Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential","volume":"38","author":"Zhang","year":"2024","journal-title":"Leukemia"},{"issue":"35","key":"2026101310430996600_bib8","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-cell lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"issue":"22","key":"2026101310430996600_bib9","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"20","key":"2026101310430996600_bib10","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"2026101310430996600_bib11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3324\/haematol.2018.190157","article-title":"Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements is not associated with MYC\/IG gene rearrangements","volume":"103","author":"McPhail","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2026101310430996600_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41408-024-01148-x","article-title":"Limited stage high grade B-cell lymphoma with MYC, BCL2 and\/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes","volume":"14","author":"Lue","year":"2024","journal-title":"Blood Cancer J"},{"issue":"12","key":"2026101310430996600_bib13","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026101310430996600_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jmoldx.2021.05.007","article-title":"LYmphoid NeXt-Generation Sequencing (LYNX) Panel: a comprehensive capture-based sequencing tool for the analysis of prognostic and predictive markers in lymphoid malignancies","volume":"23","author":"Navrkalova","year":"2021","journal-title":"J Mol Diagn"},{"issue":"1","key":"2026101310430996600_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ajcp\/aqad006","article-title":"Integrated genomic DNA\/RNA profiling vs fluorescence in situ hybridization in the detection of MYC and BCL2 (and BCL6) rearrangements in La-ge B-cell lymphomas: updates amid the new WHO classification of lymphoid neoplasms","volume":"160","author":"de Lima Guido","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2026101310430996600_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqz172","article-title":"Comparison between integrated genomic DNA\/RNA profiling and fluorescence in situ hybridization in the detection of MYC, BCL-2, and BCL-6 gene rearrangements in large B-cell lymphomas","volume":"153","author":"Cassidy","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2026101310430996600_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jmoldx.2025.01.007","article-title":"Detection of gene fusions and rearrangements in formalin-fixed, paraffin-embedded solid tumor specimens using high-throughput chromosome conformation capture","volume":"27","author":"Galbraith","year":"2025","journal-title":"J Mol Diagn"},{"issue":"3","key":"2026101310430996600_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjh.19611","article-title":"Large B-cell lymphoma with mystery rearrangement: applying Hi-C to the detection of clinically relevant structural abnormalities","volume":"205","author":"Prior","year":"2024","journal-title":"Br J Haematol"},{"issue":"17","key":"2026101310430996600_bib19","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3390\/cancers16172936","article-title":"Evaluation of Hi-C sequencing for detection of gene fusions in hematologic and solid tumor pediatric cancer samples","volume":"16","author":"Schmitt","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2026101310430996600_bib20","doi-asserted-by":"crossref","first-page":"101166","DOI":"10.1016\/j.xgen.2026.101166","article-title":"Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies","volume":"6","author":"Wu","year":"2025","journal-title":"Cell Genom"},{"issue":"7","key":"2026101310430996600_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/modpathol.2013.214","article-title":"Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"27","author":"Tzankov","year":"2014","journal-title":"Mod Pathol"},{"issue":"2","key":"2026101310430996600_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2012.066209","article-title":"Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study","volume":"98","author":"Visco","year":"2013","journal-title":"Haematologica"},{"issue":"20","key":"2026101310430996600_bib23","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2026101310430996600_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/2326-6066.CIR-18-0439","article-title":"Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL","volume":"7","author":"Xu-Monette","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"23","key":"2026101310430996600_bib25","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/1078-0432.CCR-23-1554","article-title":"Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in DLBCL","volume":"29","author":"Xu-Monette","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026101310430996600_bib26","article-title":"Arima SV Pipeline for Mapping, SV Detection and QC","volume":"2023","author":"ArimaGenomics","year":"2025","journal-title":"GitHub Repository"},{"key":"2026101310430996600_bib27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.12688\/f1000research.7334.1","article-title":"HiCUP: pipeline for mapping and processing Hi-C data","volume":"4","author":"Wingett","year":"2015","journal-title":"F1000Res"},{"issue":"10","key":"2026101310430996600_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/s41588-018-0195-8","article-title":"Integrative detection and analysis of structural variation in cancer genomes","volume":"50","author":"Dixon","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"2026101310430996600_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cels.2016.07.002","article-title":"Juicer provides a one-click system for analyzing loop-resolution Hi-C experiments","volume":"3","author":"Durand","year":"2016","journal-title":"Cell Syst"},{"issue":"1","key":"2026101310430996600_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cels.2015.07.012","article-title":"Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom","volume":"3","author":"Durand","year":"2016","journal-title":"Cell Syst"},{"issue":"9","key":"2026101310430996600_bib31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/leu.2012.83","article-title":"Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"26","author":"Visco","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"2026101310430996600_bib32","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"issue":"21","key":"2026101310430996600_bib33","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2026101310430996600_bib34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s40425-019-0730-x","article-title":"Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies","volume":"7","author":"Xu-Monette","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"14","key":"2026101310430996600_bib35","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/1078-0432.CCR-15-2296","article-title":"Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B-cell lymphoma","volume":"22","author":"Xu-Monette","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2026101310430996600_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2026101310430996600_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41375-022-01764-1","article-title":"A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas","volume":"37","author":"Falini","year":"2023","journal-title":"Leukemia"},{"issue":"26","key":"2026101310430996600_bib38","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1182\/blood-2016-05-715094","article-title":"Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma","volume":"128","author":"Xu-Monette","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2026101310430996600_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/2643-3230.BCD-25-0099","article-title":"B-cell receptor silencing reveals the origin and dependencies of high-grade B-cell lymphomas with MYC and BCL2 rearrangements","volume":"6","author":"Varano","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"5","key":"2026101310430996600_bib40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood.2024024251","article-title":"Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)","volume":"144","author":"Hilton","year":"2024","journal-title":"Blood"},{"key":"2026101310430996600_bib41","first-page":"2493","article-title":"Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population","volume":"141","author":"Alduaij","year":"2023","journal-title":"Blood"},{"issue":"3","key":"2026101310430996600_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"2026101310430996600_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"J Clin Oncol"},{"issue":"12","key":"2026101310430996600_bib44","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/s41375-025-02794-1","article-title":"Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept","volume":"39","author":"Kurz","year":"2025","journal-title":"Leukemia"},{"issue":"1","key":"2026101310430996600_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41408-024-01146-z","article-title":"Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma","volume":"14","author":"\u00d6zo\u011ful","year":"2024","journal-title":"Blood Cancer J"},{"issue":"5","key":"2026101310430996600_bib46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-21-2949","article-title":"Genetic subtyping and phenotypic characterization of the immune microenvironment and MYC\/BCL2 double expression reveal heterogeneity in diffuse large B-cell lymphoma","volume":"28","author":"Xu-Monette","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2026101310430996600_bib47","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.18632\/oncotarget.3479","article-title":"Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries","volume":"6","author":"Xu-Monette","year":"2015","journal-title":"Oncotarget"},{"issue":"18","key":"2026101310430996600_bib48","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.2024025652","article-title":"DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma","volume":"145","author":"Chapuy","year":"2025","journal-title":"Blood"},{"issue":"14","key":"2026101310430996600_bib49","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","article-title":"A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL","volume":"4","author":"Xu-Monette","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2026101310430996600_bib50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"7","key":"2026101310430996600_bib51","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.14885","article-title":"Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population","volume":"82","author":"Hesius","year":"2023","journal-title":"Histopathology"},{"key":"2026101310430996600_bib52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2022.10.011","article-title":"Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients","volume":"131","author":"Berg","year":"2023","journal-title":"Hum Pathol"},{"issue":"13","key":"2026101310430996600_bib53","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"issue":"7","key":"2026101310430996600_bib54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2026101310430996600_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","article-title":"PD-1 expression and clinical PD-1 blockade in B-cell lymphomas","volume":"131","author":"Xu-Monette","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2026101310430996600_bib56","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2025017643","article-title":"Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis","volume":"10","author":"Kong","year":"2026","journal-title":"Blood Adv"},{"key":"2026101310430996600_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/his.12178","article-title":"MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection","volume":"63","author":"Mu\u00f1oz-M\u00e1rmol","year":"2013","journal-title":"Histopathology"},{"issue":"12","key":"2026101310430996600_bib58","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.3390\/ijms25126447","article-title":"Programmed death ligand 1 (PD-L1) expression in lymphomas: state of the art","volume":"25","author":"Zanelli","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2026101310430996600_bib59","doi-asserted-by":"crossref","first-page":"e164573","DOI":"10.1172\/JCI164573","article-title":"A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma","volume":"135","author":"Kang","year":"2025","journal-title":"J Clin Invest"},{"key":"2026101310430996600_bib60","first-page":"e16882","article-title":"Anaplastic lymphoma kinase positive large B-cell lymphoma: diagnostic perils and pitfalls, an underrecognized entity","volume":"13","author":"Chowdhury","year":"2021","journal-title":"Cureus"},{"issue":"47","key":"2026101310430996600_bib61","doi-asserted-by":"crossref","first-page":"eadg2263","DOI":"10.1126\/sciadv.adg2263","article-title":"ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer","volume":"9","author":"Zhou","year":"2023","journal-title":"Sci Adv"},{"issue":"1","key":"2026101310430996600_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41408-025-01323-8","article-title":"Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma","volume":"15","author":"Shi","year":"2025","journal-title":"Blood Cancer J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6828\/2593948\/blooda_adv-2026-019675-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6828\/2593948\/blooda_adv-2026-019675-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:43:20Z","timestamp":1791902600000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6828\/569157\/Application-of-Hi-C-sequencing-to-detect-oncogene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":62,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019675","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,10,6]]}}}